Señales en vivo de 000806.SZ | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (5 jul 2023 @ 02:57):

Galaxy Biomedical Investment Co., Ltd. operates in the transmission and distribution, electronic information, and bio-pharmaceutical industries in China...

Stats
Volumen de hoy	33.86M
Volumen promedio	8.81M
Capitalización de mercado	461.96M
EPS	CNY-0.0663 ( 2023-03-31 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	-1.313
ATR14	CNY0.0550 (12.79%)

Volumen Correlación

Largo: -0.25 (neutral)

Corto: -0.56 (weak negative)

Signal:(15.824) Neutral

Galaxy Biomedical Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Galaxy Biomedical Correlación - Moneda/Commodity

-0.86
( strong negative )

-0.36
( neutral )

0.00
( neutral )

-0.60
( weak negative )

0.86
( strong )

Galaxy Biomedical Finanzas

Annual	2022
Ingresos:	CNY1.53B
Beneficio Bruto:	CNY542.64M (35.51 %)
EPS:	CNY-0.310

FY	2022
Ingresos:	CNY1.53B
Beneficio Bruto:	CNY542.64M (35.51 %)
EPS:	CNY-0.310

FY	2021
Ingresos:	CNY1.14B
Beneficio Bruto:	CNY425.76M (37.21 %)
EPS:	CNY-0.875

FY	2020
Ingresos:	CNY1.11B
Beneficio Bruto:	CNY385.19M (34.83 %)
EPS:	CNY0.0530

Financial Reports:

No articles found.

Galaxy Biomedical

Galaxy Biomedical Investment Co., Ltd. operates in the transmission and distribution, electronic information, and bio-pharmaceutical industries in China. The company produces and sells various transformer products, such as power, rectifier, and special transformers for use in metal smelting, electrochemistry, and power grid companies; and manufactures and sells electronic components, including displacement sensors, brake resistance boxes, radio frequency components, resistors, potentiometers, and others for use in aviation, aerospace, weapons, ships, AI intelligence, new energy, rail transit, communications, smart grids, instrumentation and other fields. It also offers animal products, and monoclonal antibody and targeted drugs, as well as drugs for the treatment of cancer and other diseases; laboratory equipment; and CRO, CAR-T technology and stem cell technology research and development, malignant cancer immune cell technology, and genetic testing services. The company also exports its products. The company was formerly known as Beihai Yinhe Industry Investment Co., Ltd. and changed its name to Galaxy Biomedical Investment Co., Ltd. in October 2015. Galaxy Biomedical Investment Co., Ltd. was founded in 1993 and is headquartered in Beihai, China.